First Time Loading...

Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460

Watchlist Manager
Sihuan Pharmaceutical Holdings Group Ltd Logo
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
Watchlist
Price: 0.62 HKD 1.64% Market Closed
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

1.9B
-43%
Revenue
Growth Rates:
1 Year
-15%
3 Years
-24%
5 Years
-36%
7 Years
-
10 Years
-
-140.5m
+70%
Operating Income
Growth Rates:
1 Year
+74%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
-54m
+97%
Net Income
Growth Rates:
1 Year
+97%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Earnings Waterfall
Sihuan Pharmaceutical Holdings Group Ltd

Revenue
1.9B CNY
Cost of Revenue
-564.9m CNY
Gross Profit
1.3B CNY
Operating Expenses
-1.4B CNY
Operating Income
-140.5m CNY
Other Expenses
86.5m CNY
Net Income
-54m CNY

Income Statement
Sihuan Pharmaceutical Holdings Group Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2006 Dec-2006 Mar-2007 Jun-2007 Sep-2007 Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Revenue
Revenue
149
N/A
162
+9%
178
+10%
208
+17%
241
+16%
286
+19%
344
+20%
407
+18%
464
+14%
510
+10%
546
+7%
595
+9%
1 440
+142%
2 746
+91%
2 584
-6%
2 917
+13%
3 297
+13%
2 878
-13%
2 275
-21%
2 464
+8%
3 317
+35%
3 038
-8%
2 595
-15%
2 181
-16%
3 237
+48%
1 861
-43%
Gross Profit
Cost of Revenue
(41)
(37)
(36)
(40)
(40)
(61)
(78)
(103)
(125)
(134)
(148)
(162)
(422)
(759)
(590)
(538)
(578)
(589)
(565)
(550)
(721)
(608)
(628)
(694)
(1 002)
(565)
Gross Profit
108
N/A
125
+16%
141
+13%
168
+19%
201
+19%
226
+13%
266
+18%
304
+14%
340
+12%
377
+11%
398
+6%
433
+9%
1 018
+135%
1 987
+95%
1 994
+0%
2 379
+19%
2 719
+14%
2 289
-16%
1 710
-25%
1 914
+12%
2 596
+36%
2 430
-6%
1 967
-19%
1 488
-24%
2 235
+50%
1 296
-42%
Operating Income
Operating Expenses
(12)
(16)
(18)
(30)
(37)
(44)
(62)
(75)
(85)
(100)
(109)
(137)
(220)
(522)
(465)
(655)
(821)
(895)
(1 103)
(1 429)
(1 375)
(1 754)
(1 970)
(2 024)
(2 711)
(1 436)
Selling, General & Administrative
(23)
(28)
(30)
(36)
(45)
(61)
(80)
(91)
(93)
(92)
(96)
(101)
(340)
(857)
(977)
(667)
(547)
(717)
(725)
(859)
(1 049)
(1 129)
(1 139)
(1 023)
(1 448)
(911)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(480)
(714)
(599)
(666)
(729)
(762)
(868)
(992)
(937)
(1 231)
(578)
Other Operating Expenses
11
12
12
6
8
17
18
16
8
(8)
(13)
(36)
120
335
512
492
440
421
289
159
437
243
161
(64)
(32)
53
Operating Income
96
N/A
109
+14%
124
+13%
139
+12%
164
+18%
182
+11%
204
+12%
229
+13%
255
+11%
276
+8%
289
+5%
296
+2%
798
+170%
1 465
+84%
1 529
+4%
1 724
+13%
1 898
+10%
1 395
-27%
607
-56%
486
-20%
1 221
+151%
676
-45%
(3)
N/A
(536)
-16 198%
(476)
+11%
(141)
+70%
Pre-Tax Income
Interest Income Expense
(0)
(1)
(0)
(0)
(0)
3
3
5
8
11
13
10
73
138
124
289
332
154
105
124
62
(115)
(253)
(64)
(165)
(50)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
126
126
0
0
(2 844)
(3 972)
(1 128)
156
0
(65)
(11)
(1 523)
(1 515)
29
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
95
N/A
108
+14%
123
+14%
138
+12%
163
+18%
185
+13%
206
+12%
235
+14%
263
+12%
287
+9%
303
+5%
306
+1%
997
+226%
1 729
+73%
1 653
-4%
2 012
+22%
(614)
N/A
(2 423)
-295%
(416)
+83%
766
N/A
1 283
+68%
496
-61%
(267)
N/A
(2 123)
-694%
(2 156)
-2%
(161)
+93%
Net Income
Tax Provision
(16)
(18)
(20)
(5)
(6)
(6)
(6)
(28)
(33)
(54)
(63)
(67)
(157)
(250)
(228)
(333)
(435)
(290)
(187)
(219)
(311)
(253)
(180)
(197)
(283)
(96)
Income from Continuing Operations
79
90
103
134
158
179
200
207
231
234
240
240
840
1 479
1 425
1 679
(1 049)
(2 713)
(603)
547
972
243
(447)
(2 320)
(2 439)
(258)
Income to Minority Interest
0
0
1
1
1
1
0
3
2
4
5
9
2
(30)
(53)
(59)
(95)
4
66
(39)
(27)
184
303
368
438
204
Net Income (Common)
79
N/A
91
+14%
104
+15%
134
+29%
158
+18%
179
+13%
200
+12%
210
+5%
233
+11%
237
+2%
245
+3%
249
+2%
842
+238%
1 449
+72%
1 372
-5%
1 620
+18%
(1 166)
N/A
(2 753)
-136%
(583)
+79%
473
N/A
935
+97%
417
-55%
(155)
N/A
(1 915)
-1 139%
(1 965)
-3%
(54)
+97%
EPS (Diluted)
0.1
N/A
0.11
+10%
0.13
+18%
0.15
+15%
0.17
+13%
0.2
+18%
0.22
+10%
0.23
+5%
0.25
+9%
0.25
N/A
0.25
N/A
0.26
+4%
0.09
-65%
0.15
+67%
0.14
-7%
0.17
+21%
-0.12
N/A
-0.29
-142%
-0.06
+79%
0.05
N/A
0.1
+100%
0.04
-60%
-0.02
N/A
-0.21
-950%
-0.21
N/A
-0.01
+95%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.